Single Ascending Dose Study With Healthy Male Volunteers and Type II Diabetic Patients

NCT00886366 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
26
Enrollment
INDUSTRY
Sponsor class

Stopped Part A reached a predefined stopping criteria. Relevant doses for part B could not be established based on A and subsequently study was stopped.

Conditions

Interventions

Sponsor

AstraZeneca